How to Buy Tg Therapeutics Stock
Tg Therapeutics Inc
TG Therapeutics, Inc. , a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Tg Therapeutics stock last closed at $22.19, down 0.85% from the previous day, and has increased 178.77% in one year. It has overperformed other stocks in the Biotechnology industry by 1.91 percentage points. Tg Therapeutics stock is currently +243.5% from its 52-week low of $6.46, and -15.98% from its 52-week high of $26.41.
As of Oct 3, 2024, there are 154.82M shares of TGTX outstanding. The market cap of TGTX is $3.44B. In the past 24 hours, 1.31M TGTX shares were traded.
How to Buy Tg Therapeutics Stock
Not sure how to invest in Tg Therapeutics stock? Here's how.
- Decide where to buy Tg Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you choose where to buy Tg Therapeutics stock.
- Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Pick your method of payment and add your info.
- Research Tg Therapeutics stock: The Tg Therapeutics ticker symbol is TGTX. Is Tg Therapeutics stock a good investment? Should you buy shares of TGTX? How do TGTX's underlying business fundamentals look? Do top analysts think Tg Therapeutics is a good buy? Why has TGTX's stock price moved recently? (Hint: Our stock market analysis tools can help you evaluate if TGTX is a good stock to buy).
- Execute your TGTX trade: Decide if you will purchase TGTX shares at the current market price or use a limit order to buy TGTX shares at a specific price.
- Get key alerts regarding your investment in TGTX: Create a watchlist to watch your investment in Tg Therapeutics shares.
Step 1: Decide where to buy Tg Therapeutics stock
You will need an online brokerage account in order to access the NASDAQ market and buy TGTX shares.
Our favorite brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world markets: From Technology to Energy, New York to Tokyo — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now.
Open eToro AccountStep 2: Open your brokerage account
Now that you've selected the best brokerage, it's time to fill out some personal information so you can invest in TGTX today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to create your new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've finished signing up on our top ranked stock trading app, you can securely and quickly fund your account:
Watch this video walkthrough for more details depositing money into your new investment account.
Step 4: Research Tg Therapeutics stock
Once you have selected the best place to buy Tg Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you actually wrap your head around the risk as well as the upside.
Tg Therapeutics shares at a glance
Tg Therapeutics Overview
WallStreetZen was built to help average investors do more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on TGTX's stock page.
Is TGTX stock properly valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge TGTX's fair value.
Using relative valuations measures:
- TGTX could be undervalued based on its P/E ratio of 32.63x, relative to Biotechnology industry P/E ratio of -109.51x
- TGTX may be overvalued based on its P/B ratio of 19.35x, relative to Biotechnology industry P/B ratio of 5.92x
- TGTX could be overvalued based on its PEG ratio of 1.15x
You can access more valuation analysis on TGTX's stock here.
Is TGTX a healthy company?
Positive Health Checks:
- There are more short-term assets than short-term liabilities on the TGTX balance sheet.
- There are more short-term assets than long-term liabilities on the TGTX balance sheet.
- TGTX's operating cash flow of $67.82M allows it to safely service it's debt of $111.23M.
- Total TGTX debt is lower than 5 years ago, relative to shareholder equity.
- TGTX earnings of $108.19M is not sufficient to cover its interest payments.
- TGTX profit margin has gone up from -730.3% to 27.6% in the past year.
Negative Health Checks:
- TGTX has a relatively high debt to equity ratio of 1.26.
Is it a good time to buy TGTX stock, according to analysts?
Out of 5 Equities analysts who give forecasts on TGTX, the consensus analyst rating on TGTX is a Strong Buy
It's important to keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Tg Therapeutics stock forecast page.
TGTX Technical Indicators
TGTX Growth Numbers
Last year, TGTX revenue was $346.73M. During the last 5 year, TGTX's revenue has grown by 369.49% per year. This was faster than the Biotechnology industry average of 59.85%.
You can research TGTX's earnings and revenue performance here.
Latest Insiders Trades at TGTX
In the last 12 months, insiders at TGTX have sold more shares than they have bought.
Sagar Lonial, Director of TGTX, was the latest TGTX insider to sell. They sold $275,790.76 worth of TGTX shares on Jun 20, 2024.
Learn more about who owns TGTX stock here.
Does TGTX stock generate passive income?
No, Tg Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about TGTX
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Execute your TGTX trade
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually sufficient. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a specific dollar amount limit, place a limit order.
Hit the Open button and your broker will place the order.
If you want additional help with investing in stocks on eToro, click the how to video below:
Step 6: Get key alerts regarding your investment in TGTX
Now that you own some shares in TGTX, you'll want to stay up-to-date on your investment.
Start a watchlist to keep tabs on your TGTX stock.
TGTX Feed
How to Buy Stock in Tg Therapeutics
To summarize, here are the 6 steps to buy stock in Tg Therapeutics:
- Decide where to buy Tg Therapeutics stock
- Open your brokerage account
- Deposit money your brokerage account
- Research Tg Therapeutics stock
- Execute your TGTX trade
- Get key alerts regarding your investment in TGTX
If you require a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to track your new investment in Tg Therapeutics, create your watchlist below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.